Synthomer (LON:SYNT) PT Lowered to GBX 265

Share on StockTwits

Synthomer (LON:SYNT) had its target price reduced by equities researchers at Deutsche Bank from GBX 410 ($5.39) to GBX 265 ($3.49) in a research report issued to clients and investors on Wednesday, Stock Target Advisor reports. The brokerage presently has a “buy” rating on the stock. Deutsche Bank’s price objective points to a potential upside of 14.42% from the stock’s current price.

Several other equities research analysts have also weighed in on SYNT. JPMorgan Chase & Co. reduced their price objective on Synthomer from GBX 300 ($3.95) to GBX 242 ($3.18) and set a “neutral” rating for the company in a research note on Tuesday. Peel Hunt reissued a “hold” rating on shares of Synthomer in a research note on Thursday, March 5th. Canaccord Genuity reduced their price objective on Synthomer from GBX 460 ($6.05) to GBX 450 ($5.92) and set a “buy” rating for the company in a research note on Wednesday, February 12th. UBS Group reissued a “neutral” rating on shares of Synthomer in a research note on Monday, March 2nd. Finally, Jefferies Financial Group reduced their price objective on Synthomer from GBX 375 ($4.93) to GBX 270 ($3.55) and set a “buy” rating for the company in a research note on Tuesday, March 17th. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of GBX 329.67 ($4.34).

SYNT opened at GBX 231.60 ($3.05) on Wednesday. The firm has a market cap of $983.96 million and a PE ratio of 10.82. The company has a quick ratio of 0.99, a current ratio of 1.41 and a debt-to-equity ratio of 20.75. The business has a fifty day simple moving average of GBX 281.78 and a 200-day simple moving average of GBX 309.26. Synthomer has a fifty-two week low of GBX 182.30 ($2.40) and a fifty-two week high of GBX 397.29 ($5.23).

About Synthomer

Synthomer plc operates as a specialty chemicals company in Europe, North America, Asia, and internationally. The company offers pressure-sensitive adhesives, acrylic polymers, acrylic dispersions, and other adhesives; latices for foamed bedding products and footwear; and binders for carpet applications.

Further Reading: Why do companies engage in swaps?

Analyst Recommendations for Synthomer (LON:SYNT)

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

TORC Oil and Gas  Price Target Raised to C$1.50 at Scotiabank
TORC Oil and Gas Price Target Raised to C$1.50 at Scotiabank
$94.13 Million in Sales Expected for Kinsale Capital Group Inc  This Quarter
$94.13 Million in Sales Expected for Kinsale Capital Group Inc This Quarter
Critical Comparison: Castle Biosciences  & Its Peers
Critical Comparison: Castle Biosciences & Its Peers
Analyzing INmune Bio  and Its Peers
Analyzing INmune Bio and Its Peers
Zacks: Analysts Anticipate Global Medical REIT Inc  Will Announce Quarterly Sales of $21.04 Million
Zacks: Analysts Anticipate Global Medical REIT Inc Will Announce Quarterly Sales of $21.04 Million
Head-To-Head Contrast: Benefytt Technologies  vs. The Competition
Head-To-Head Contrast: Benefytt Technologies vs. The Competition


 
© 2006-2020 Zolmax.